(19)
(11) EP 1 644 404 A2

(12)

(43) Date of publication:
12.04.2006 Bulletin 2006/15

(21) Application number: 04766228.3

(22) Date of filing: 15.07.2004
(51) International Patent Classification (IPC): 
C07K 14/165(1995.01)
C12N 15/50(1990.01)
C12N 15/13(1990.01)
A61P 31/14(2000.01)
 C07K 16/10(1995.01)
C12N 15/63(1990.01)
C12N 5/10(1990.01)
(86) International application number:
PCT/EP2004/051498
(87) International publication number:
WO 2005/012337 (10.02.2005 Gazette 2005/06)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 15.07.2003 WO PCT/EP03/50308
24.07.2003 WO PCT/EP03/50333
02.09.2003 WO PCT/EP03/50392
27.10.2003 WO PCT/EP03/50761
24.11.2003 WO PCT/EP03/50883

(71) Applicant: Crucell Holland B.V.
2333 CN Leiden (NL)

(72) Inventors:
  • TER MEULEN, Jan, Henrik
    1016 CX Amsterdam (NL)
  • GOUDSMIT, Jaap
    NL-1075 CX Amsterdam (NL)
  • SLOOTSTRA, Jelle Wouter
    NL-8232 AJ Lelystad (NL)
  • TIMMERMAN, Peter
    NL-8212 DT Lelystad (NL)
  • DE KRUIF, Cornelis Adriaan
    NL-3731 EL De Bilt (NL)
  • VAN DEN BRINK, Edward Norbert
    NL-1165 NS Halfweg (NL)

(74) Representative: Klein, Bart 
Crucell Holland B.V. IP Department Archimedesweg 4
2333 CN Leiden
2333 CN Leiden (NL)

   


(54) ANTIGENIC PEPTIDES OF SARS CORONAVIRUS AND USES THEREOF